Segment Information (Tables)

9 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Schedule of segment performance measures

Nine Months Ended March 31, 2015 and 2014:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2015
Net sales	$	160,808	$	111,104	$	128,452	$	-		$	400,364
Gross profit		50,829		19,750		23,689		-			94,268
Income (loss) before income taxes		21,096		5,393		9,925		(4,658	)		31,756
2014
Net sales	$	112,457	$	133,746	$	124,396	$	-		$	370,599
Gross profit		34,244		30,443		20,994		-			85,681
Income (loss) before income taxes		14,961		17,328		9,008		(5,089	)		36,208

Three months Ended March 31, 2015 and 2014:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2015
Net sales	$	56,305	$	40,548	$	48,943	$	-		$	145,796
Gross profit		19,957		6,674		9,967		-			36,598
Income (loss) before income taxes		8,667		1,533		5,105		(1,679	)		13,626
2014
Net sales	$	33,946	$	47,843	$	43,041	$	-		$	124,830
Gross profit		10,076		7,408		7,479		-			24,963
Income (loss) before income taxes		3,234		2,798		3,555		(1,683	)		7,904